Consolidated Net Income/Loss: A company's total income or loss before preferred stock dividends.
Corbus Pharmaceuticals Holdings, Inc. (CRBP) had Consolidated Net Income/Loss of $-22.97M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-22.97M |
|
-- |
|
-- |
|
$24.30M |
|
$-24.30M |
|
$1.33M |
|
$-22.97M |
|
$-22.97M |
|
$-22.97M |
|
$-22.97M |
|
|
Consolidated Net Income/Loss |
$-22.97M |
$-22.97M |
|
$-24.30M |
|
$-24.60M |
|
18.71M |
|
18.71M |
|
$-1.23 |
|
$-1.23 |
|
| Balance Sheet Financials | |
$143.57M |
|
$0.12M |
|
$0.91M |
|
$144.48M |
|
$18.14M |
|
-- |
|
-- |
|
$18.14M |
|
$126.34M |
|
$126.34M |
|
$126.34M |
|
17.74M |
|
| Cash Flow Statement Financials | |
$-25.57M |
|
$22.45M |
|
-- |
|
$29.16M |
|
$26.05M |
|
$-3.12M |
|
$1.92M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.92 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-25.58M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-18.18% |
|
-18.18% |
|
-15.90% |
|
-18.18% |
|
$7.12 |
|
$-1.37 |
|
$-1.37 |
|